Gene therapy trial seeks to free hemophilia patients from frequent injections
NCT ID NCT07226206
Summary
This early-stage study is testing the safety of an experimental gene therapy called SPK-8011QQ in adult men with severe hemophilia A. The main goal is to see if the treatment is safe and well-tolerated, not to prove it works. Researchers will carefully monitor five participants for any side effects after they receive a single dose of the therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kaiser Permanente
Vallejo, California, 94589-2441, United States
Conditions
Explore the condition pages connected to this study.